A web-based survey of UK pharmacists to assess the effectiveness of Viagra Connect^® additional risk minimisation measures.

ABSTRACT: Background To support reclassification in the UK of sildenafil citrate (50 mg) from prescription-only medicine to a pharmacy medicine (P status) under the brand name "Viagra Connect^®", additional risk minimisation measures were implemented that included training materials and an optional checklist to assist community pharmacists in the safe supply of Viagra Connect^® to suitable patients. Objective To evaluate the effectiveness of Viagra Connect^® additional risk minimisation measures by assessing community pharmacists' participation in training, their knowledge of key risk messages, and utilisation of the checklist. Setting A post-authorisation safety study implemented as a web-based survey, conducted in a representative population of UK community pharmacist

SUBMITTER: Lem J 

PROVIDER: S-EPMC9200697 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature